Drugs / mRNA transfected dendritic cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01446731 | Oct 2011 → Aug 2015 | prostate neoplasm | Inge Marie Svane | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA transfected dendritic cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01446731 ↗ |
| Modality | Cell therapy | “DC vaccine (mRNA transfected dendritic cell)” NCT01446731 ↗ |
| Route | Other | “5x 10e6 DCs are given as intradermal injections” NCT01446731 ↗ |